1|Page
NRNP 6665 Midterm Exam 2025/ 2026 – Walden
University | 100% Verified Questions and Correct
Answers (NRNP6665N / NRNP-6665N)||Latest Exam!!!
Question 18:
Christine is a 9-year-old female who presents for care
after having been placed in the local foster care system.
She has been in and out of foster care for the last 4 years
after her parents were killed in an automobile accident.
Christine has been placed in a variety of homes and
residential care facilities. The PMHNP recognizes that
Christine is at high risk for: - Answer-A. Dissociative
disorders
B. Post-traumatic stress disorder
C. Impulse-control disorder
D. Attachment disorder
Question 7:
Caylee is a 5-year-old girl who is referred for evaluation by
child protective services. She was recently removed from
her biological family and placed in foster care, as her
home environment was reportedly unsafe due to
conditions of extreme neglect. Her foster mother reports
that Caylee is very quiet and withdrawn and always
,2|Page
appears sad and disinterested in her surroundings;
however, she becomes very irritable when anything
unexpected or unplanned occurs. The foster mother
became very concerned when it appeared that Caylee
was hallucinating. The PMHNP considers that: - Answer-A.
Caylee is at high risk for suicide and precautions should
be taken
B. The hallucinations are consistent with brief psychotic
disorder or schizophrenia
C. The history and reported symptoms are typical of
depressive disorder in young children
D. This is a common situation when prepubertal children
are removed from the biological parents regardless of how
dysfunctional they are
Question 2:
Debi is a 15-year-old girl who is currently being treated for
depression. Her parents have been very proactive and
involved in her care, and Debi has achieved remission 2
months after beginning treatment with a combination of
pharmacotherapy and cognitive behavioral therapy. While
counseling Debi's parents about important issues in
management, the PMHNP advises that: - Answer-A. There
is a > 50% likelihood that Debi's younger sibling will
develop depressive symptoms
,3|Page
B. The mean length of major depressive episode in
adolescents is 4 months
C. 20 to 40% of adolescents who have major depressive
disorder will develop bipolar I within 5 years
D. Adolescent-onset depression typically need long-term
pharmacologic management to prevent relapses
Agomelatine - Answer-Brand: Valdoxan
-Melatonin multimodal (Mel-MM)
-Agonist at melatonergic 1 and melatonergic 2 receptors
-Antagonist at 5HT2C receptors
-Not FDA approved: Rx for Depression, Generalized
anxiety disorder
-Initial 25 mg/day at bedtime; after 2 weeks can increase
to 50 mg/day at bedtime
Amitriptyline (Elavil) - Answer-Tricyclic antidepressant.
Aripiprazole (Abilify) - Answer-Treatment for depression.
Atypical antipsychotic. "Dopamine stabilizer". Dopamine
receptor antagonist in high concentration and also
, 4|Page
stimulates increase of dopamine in low concentrations.
Side effects: insomnia, akathisia.
Brexpiprazole (Rexulti) - Answer-Treatment for
depression. Atypical antipsychotic
Bupropion (Wellbutrin) - Answer-Antidepressant and
smoking cessation aid, It can treat depression and help
people quit smoking. It can also prevent depression
caused by seasonal affective disorder (SAD).
Citalopram (Celexa) - Answer-Antidepressant, SSRI: 20-
40 mg qd.
Clomipramine (Anafranil) - Answer--Serotonin reuptake
inhibitor (S-RI)
-Tricyclic antidepressant (TCA)
-Parent drug is a potent serotonin reuptake inhibitor
Active metabolite is a potent norepinephrine/noradrenaline
reuptake inhibitor
-Increases serotonergic neurotransmission by blocking the
serotonin reuptake pump (transporter), -Desensitization of
serotonin receptors, especially serotonin 1A receptors
NRNP 6665 Midterm Exam 2025/ 2026 – Walden
University | 100% Verified Questions and Correct
Answers (NRNP6665N / NRNP-6665N)||Latest Exam!!!
Question 18:
Christine is a 9-year-old female who presents for care
after having been placed in the local foster care system.
She has been in and out of foster care for the last 4 years
after her parents were killed in an automobile accident.
Christine has been placed in a variety of homes and
residential care facilities. The PMHNP recognizes that
Christine is at high risk for: - Answer-A. Dissociative
disorders
B. Post-traumatic stress disorder
C. Impulse-control disorder
D. Attachment disorder
Question 7:
Caylee is a 5-year-old girl who is referred for evaluation by
child protective services. She was recently removed from
her biological family and placed in foster care, as her
home environment was reportedly unsafe due to
conditions of extreme neglect. Her foster mother reports
that Caylee is very quiet and withdrawn and always
,2|Page
appears sad and disinterested in her surroundings;
however, she becomes very irritable when anything
unexpected or unplanned occurs. The foster mother
became very concerned when it appeared that Caylee
was hallucinating. The PMHNP considers that: - Answer-A.
Caylee is at high risk for suicide and precautions should
be taken
B. The hallucinations are consistent with brief psychotic
disorder or schizophrenia
C. The history and reported symptoms are typical of
depressive disorder in young children
D. This is a common situation when prepubertal children
are removed from the biological parents regardless of how
dysfunctional they are
Question 2:
Debi is a 15-year-old girl who is currently being treated for
depression. Her parents have been very proactive and
involved in her care, and Debi has achieved remission 2
months after beginning treatment with a combination of
pharmacotherapy and cognitive behavioral therapy. While
counseling Debi's parents about important issues in
management, the PMHNP advises that: - Answer-A. There
is a > 50% likelihood that Debi's younger sibling will
develop depressive symptoms
,3|Page
B. The mean length of major depressive episode in
adolescents is 4 months
C. 20 to 40% of adolescents who have major depressive
disorder will develop bipolar I within 5 years
D. Adolescent-onset depression typically need long-term
pharmacologic management to prevent relapses
Agomelatine - Answer-Brand: Valdoxan
-Melatonin multimodal (Mel-MM)
-Agonist at melatonergic 1 and melatonergic 2 receptors
-Antagonist at 5HT2C receptors
-Not FDA approved: Rx for Depression, Generalized
anxiety disorder
-Initial 25 mg/day at bedtime; after 2 weeks can increase
to 50 mg/day at bedtime
Amitriptyline (Elavil) - Answer-Tricyclic antidepressant.
Aripiprazole (Abilify) - Answer-Treatment for depression.
Atypical antipsychotic. "Dopamine stabilizer". Dopamine
receptor antagonist in high concentration and also
, 4|Page
stimulates increase of dopamine in low concentrations.
Side effects: insomnia, akathisia.
Brexpiprazole (Rexulti) - Answer-Treatment for
depression. Atypical antipsychotic
Bupropion (Wellbutrin) - Answer-Antidepressant and
smoking cessation aid, It can treat depression and help
people quit smoking. It can also prevent depression
caused by seasonal affective disorder (SAD).
Citalopram (Celexa) - Answer-Antidepressant, SSRI: 20-
40 mg qd.
Clomipramine (Anafranil) - Answer--Serotonin reuptake
inhibitor (S-RI)
-Tricyclic antidepressant (TCA)
-Parent drug is a potent serotonin reuptake inhibitor
Active metabolite is a potent norepinephrine/noradrenaline
reuptake inhibitor
-Increases serotonergic neurotransmission by blocking the
serotonin reuptake pump (transporter), -Desensitization of
serotonin receptors, especially serotonin 1A receptors
